Risankizumab-rzaa injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults whose psoriasis is too severe to be treated by topical medications alone. Risankizumab-rzaa is in a class of medications called monoclonal antibodies. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.

Brand name: Skyrizi.

Click HERE to learn more about guselkumab at MedlinePlus (U.S. Library of Medicine)

Remember— When it comes to PRP…